Hyperbilirubinemia Following Retroperitoneal Mass Resection in a Patient with Sickle Cell Anemia.

Claire M de la Calle, Eric D Young, Nirmish Singla
Author Information
  1. Claire M de la Calle: Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD.
  2. Eric D Young: Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD.
  3. Nirmish Singla: Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: nsingla2@jhmi.edu.

Abstract

No abstract text available.

References

  1. Postgrad Med J. 1996 Aug;72(850):487-8 [PMID: 8796214]
  2. HPB (Oxford). 2011 Jan;13(1):1-14 [PMID: 21159098]
  3. J Clin Med. 2019 Sep 18;8(9): [PMID: 31540390]
  4. Arch Dis Child. 2021 Apr;106(4):315-320 [PMID: 33177052]
  5. World J Gastrointest Pathophysiol. 2017 Aug 15;8(3):108-116 [PMID: 28868180]
  6. Cureus. 2019 Oct 30;11(10):e6032 [PMID: 31824799]

Grants

  1. T32 CA193145/NCI NIH HHS

MeSH Term

Humans
Hyperbilirubinemia
Anemia, Sickle Cell

Word Cloud

Created with Highcharts 10.0.0HyperbilirubinemiaFollowingRetroperitonealMassResectionPatientSickleCellAnemia

Similar Articles

Cited By